A Phase 1a/1b multicenter, open-label dose escalation/expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor activity of PLN-101095 as monotherapy and in combination with pembrolizumab in adult par…

Cancer Internal Medicine Adult Subjects

This is a Phase 1a/1b, dose-escalation/expansion, consecutive-cohort, open-label study to evaluate the safety, tolerability, PK, PD, and preliminary evidence of antitumor activity of PLN-101095 in combination with pembrolizumab (the study treatment regimen) in adult participants with advanced or metastatic solid tumors for which pembrolizumab is indicated but have documented disease progression (refractory \[primary resistance\]) or relapsed \[secondary resistance\]) after at least 3 months from the start of treatment with pembrolizumab.

The study will consist of 2 main parts:

* Part 1: Consecutive dose-escalation cohorts using a Bayesian optimal interval (BOIN) dose escalation design with accelerated titration
* Part 2: Dose-expansion cohorts using Simon's 2-stage design

ACCL2531: A Randomized Double-Blinded Trial of Xylitol Dental Wipes for the Prophylaxis of Bloodstream Infections from Oral Organisms in Pediatric Patients with Acute Myeloid Leukemia

Cancer Pediatrics Leukemia Fungal Infectious Diseases Infectious Disease Pediatric Subjects Adult Subjects

This phase III trial compares the effect of xylitol dental wipes to dental wipes without xylitol for the reduction of bloodstream infection in children with acute myeloid leukemia (AML). Xylitol is a naturally occurring sugar compound found in fruits and vegetables. Xylitol has been shown to limit the growth of bacteria in the mouth, and to reduce cavities, plaque on the teeth, and inflammation of the gums. Treatment for AML includes chemotherapy. Patients receiving chemotherapy for AML have a risk of developing bloodstream infections. Bloodstream infections can make patients very sick, can contribute to delays in treatment, and can even cause death. In AML patients, bacteria or fungus (yeast) can sometimes enter the bloodstream from the mouth. Using xylitol dental wipes may help to reduce bloodstream infections in children being treated for AML.

HCCC-A PHASE 1 DOSE FINDING, SAFETY, AND PRELIMINARY CLINICAL ACTIVITY STUDY OF VT-101 IN ADVANCED OVARIAN CANCER

Cancer Gynecology Ovarian Cancer Electrophysiology Adult Subjects Female Subjects

This Phase 1, open-label study will evaluate VT-101, an investigational small-molecule therapy, in adult women with advanced, recurrent, or relapsed epithelial ovarian cancer. The primary objectives are to assess the safety, tolerability, and pharmacokinetic profile of VT-101 and to identify a recommended dose for further study. Secondary and exploratory objectives include evaluation of preliminary antitumor activity and characterization of treatment-related effects in participants with limited standard treatment options.

A PHASE 3 RANDOMIZED CONTROLLED TRIAL OF RONDECABTAGENE AUTOLEUCEL, AN AUTOLOGOUS, DUAL-TARGETING CD19/CD20 CAR T-CELL PRODUCT CANDIDATE, VERSUS INVESTIGATOR’S CHOICE OF CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMP…

Cancer Internal Medicine Lymphoma Adult Subjects

This Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-targeting CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients with relapsed or refractory large B-cell lymphoma in the second-line setting.